Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00226330

Public ClinicalTrials.gov record NCT00226330. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 2:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Multi-Centre, Active-Controlled (15, 30, and 45 mg Pioglitazone) Long-Term Extension Study to Evaluate the Safety and Tolerability of Tesaglitazar (0.5 and 1 mg) in Patients With Type 2 Diabetes Mellitus (GALLEX 6)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a parallel-group, multi-center, long-term extension study from the GALLANT 6 study to monitor the safety and tolerability of oral tesaglitazar compared with pioglitazone in patients with type 2 diabetes for up to 104 weeks of treatment. The total duration, including treatment and follow-up, is 107 weeks.

Study identification

NCT ID
NCT00226330
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,100 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2005
Primary completion
Nov 30, 2006
Completion
Nov 30, 2006
Last update posted
Nov 18, 2010

2005 – 2006

United States locations

U.S. sites
110
U.S. states
33
U.S. cities
110
Facility City State ZIP Site status
Research Site Birmingham Alabama
Research Site Columbiana Alabama
Research Site Mobile Alabama
Research Site Chandler Arizona
Research Site Mesa Arizona
Research Site Phoenix Arizona
Research Site Sierra Vista Arizona
Research Site Tucson Arizona
Research Site Jonesboro Arkansas
Research Site Little Rock Arkansas
Research Site Searcy Arkansas
Research Site Anaheim California
Research Site Carmichael California
Research Site Dinuba California
Research Site Elk Grove California
Research Site Encinitas California
Research Site Encino California
Research Site Fresno California
Research Site Greenbrae California
Research Site Loma Linda California
Research Site Long Beach California
Research Site Los Angeles California
Research Site Mission Viejo California
Research Site Northridge California
Research Site Pasadena California
Research Site Redondo Beach California
Research Site Riverside California
Research Site Sacramento California
Research Site Santa Ana California
Research Site Santa Monica California
Research Site Spring Valley California
Research Site Tustin California
Research Site Walnut Creek California
Research Site West Hills California
Research Site Newark Delaware
Research Site Washington D.C. District of Columbia
Research Site Brandon Florida
Research Site Cooper City Florida
Research Site Delray Beach Florida
Research Site Gainesville Florida
Research Site Hialeah Florida
Research Site Hollywood Florida
Research Site Jacksonville Florida
Research Site Melbourne Florida
Research Site Miami Florida
Research Site Ocoee Florida
Research Site Orlando Florida
Research Site Plantation Florida
Research Site West Palm Beach Florida
Research Site Atlanta Georgia
Research Site Augusta Georgia
Research Site Columbus Georgia
Research Site Dunwoody Georgia
Research Site Berwyn Illinois
Research Site Chicago Illinois
Research Site Elk Grove Village Illinois
Research Site Gurnee Illinois
Research Site Melrose Park Illinois
Research Site North Chicago Illinois
Research Site Peoria Illinois
Research Site Sterling Illinois
Research Site Indianapolis Indiana
Research Site Des Moines Iowa
Research Site Waterloo Iowa
Research Site Topeka Kansas
Research Site Witchita Kansas
Research Site Lexington Kentucky
Research Site Louisville Kentucky
Research Site New Orleans Louisiana
Research Site Slidell Louisiana
Research Site Baltimore Maryland
Research Site Columbia Maryland
Research Site Haverhill Massachusetts
Research Site Petoskey Michigan
Research Site Excelsior Springs Missouri
Research Site Richmond Heights Missouri
Research Site Rolla Missouri
Research Site Las Vegas Nevada
Research Site North Las Vegas Nevada
Research Site Pahrump Nevada
Research Site Reno Nevada
Research Site Pleasantville New Jersey
Research Site Manlius New York
Research Site New York New York
Research Site Olean New York
Research Site Staten Island New York
Research Site Asheville North Carolina
Research Site Winston-Salem North Carolina
Research Site Cincinnati Ohio
Research Site Lakewood Ohio
Research Site Oklahoma City Oklahoma
Research Site Medford Oregon
Research Site Portland Oregon
Research Site Altoona Pennsylvania
Research Site Erie Pennsylvania
Research Site Philadelphia Pennsylvania
Research Site Reading Pennsylvania
Research Site Warminster Pennsylvania
Research Site West Chester Pennsylvania
Research Site Columbia South Carolina
Research Site Memphis Tennessee
Research Site Carrollton Texas
Research Site Dallas Texas
Research Site North Richland Hills Texas
Research Site San Antonio Texas
Research Site Salt Lake City Utah
Research Site Norfolk Virginia
Research Site Virginia Beach Virginia
Research Site Gig Harbor Washington
Research Site Huntington West Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00226330, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2010 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00226330 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →